Nanogen Moves Ahead With New Microarray System After FDA Warning
A warning letter issued to San Diego-based Nanogen Aug. 11 highlights the continued focus of the agency's in vitro diagnostic regulators on analyte-specific reagents (ASRs)
More from Archive
More from Medtech Insight
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
At AAOS, orthopedics players showcased their latest robotic-assisted platforms, power tools, 3D printed technologies and software offerings. This article brings you highlights from interviews Medtech Insight conducted on site with representatives from J&J, Stryker, Materialise and Canary Medical.
A New South Korean law, the Digital Medical Products Act, enhances regulation for digital health products. Medical devices in the country are categorized both by risk and by similarity to already authorized devices. The approval process may stretch to 515 days for new manufacturers.